| 
		 
		 cardiology database
		 
		  
		ESC 2011 Paris conference coverage 
		
		News clinical trials presented at ESC 2011 Paris 
		 
		 
		
			
			ARISTOTLE, 2011 
			
			-
			
				apixaban 5mg twice daily
 vs warfarin adjusted for an INR between 2 and 3 
			
		 
			
				   
				
				atrial fibrillation - antithrombotics - primary prevention of thromboembolic events
				
			 
			
				   
				
				atrial fibrillation - direct factor Xa inhibitors - all type of patients 
				
			 
			
				   
				
				atrial fibrillation - new oral anticoagulants - all type of patients
				
			 
			
				   
				
				NMA Bayer - new oral anticoagulants - all types of patients
				
			 
			
				   
				
				NMA BMS apixaban Afib - new oral anticoagulants - ARISTOFLE
				
			 
 
 
		
		Choose another conferences:
		 
			
				
					AHA 2012 Los Angeles 
				
			
			
				
					ESC 2012 München 
				
			
			
				
					AHA 2011 Orlando 
				
			
			
				
					TCT 2011 
				
			
			
				
					ESC 2011 Paris 
				
			
			
				
					ACC 2011 New Orleans 
				
			
			
				
					ESC 2010 Stockholm 
				
			
			
				
					ACC 2010 Atlanta 
				
			
			
				
					European Society of Cardiology 2009 Congress  
				
			
			
				
					ACC.09/i2  Orlando 2009 
				
			
			
				
					AHA 2009 Orlando 
				
			
			
				
					TCT 2010 
				
			
			
				
					AHA 2010 Chicago 
				
			
			
				
					ACC 2012 
				
			
		 
		 
		 
		
		 |